Safety and Tolerability of Adipose-Derived Mesenchymal Stem Cell (ADR-001) Therapy for IgA Nephropathy
Key Points. IgA nephropathy often requires KRT. Mesenchymal stem cells offer clinical benefits. Adipose-derived mesenchymal stem cells are safe and tolerable. Background. IgA nephropathy (IgAN) often requires KRT because of its refractoriness and because corticosteroids pose infection risks. However...
Saved in:
| Main Authors: | Akihito Tanaka, Kazuhiro Furuhashi, Kumiko Fujieda, Asuka Horinouchi, Kayaho Maeda, Shoji Saito, Tetsushi Mimura, Yosuke Saka, Tomohiko Naruse, Takuji Ishimoto, Noritoshi Kato, Tomoki Kosugi, Fumie Kinoshita, Yachiyo Kuwatsuka, Yasuhiro Nakai, Shoichi Maruyama |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer - Lippincott Williams & Wilkins
2024-11-01
|
| Series: | Kidney360 |
| Online Access: | http://journals.lww.com/10.34067/KID.0000000000000563 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
WCN24-1446 The Role of Long Non-Coding RNAs in the Progression of Renal Fibrosis
by: TAKUJI ISHIMOTO, et al.
Published: (2024-04-01) -
Establishment of the NUMNi001-A human iPSC line from peripheral blood mononuclear cells of a healthy male donor
by: Akihito Tanaka, et al.
Published: (2025-09-01) -
In vivo efficacy and safety of systemically administered serinol nucleic acid-modified antisense oligonucleotides in mouse kidney
by: Toshiki Tsuboi, et al.
Published: (2025-03-01) -
In vivo efficacy and safety of systemically administered serinol nucleic acid-modified antisense oligonucleotides in mouse kidney
by: Toshiki Tsuboi, et al.
Published: (2025-03-01) -
Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocol.
by: Shinobu Shimizu, et al.
Published: (2025-01-01)